Observational Study of the Safety of an Ultra-Rush Sublingual Immunotherapy Regimen to Treat Rhinitis due to House Dust Mites
Roger, A. ; Justicia, J.-L. ; Navarro, L.Á. ; Eseverri, J.L. ; Ferrès, J. ; Malet, A. ; Alvà, V.
Int Arch Allergy Immunol 2011;154:69-75
Acceso libre

Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study
Pfaar, O. ; Barth, C. ; Jaschke, C. ; Hörmann, K. ; Klimek, L.
Int Arch Allergy Immunol 2011
Acceso libre

The Induced Regulatory T Cell Level, Defined as the Proportion of IL-10+Foxp3+ Cells among CD25+CD4+ Leukocytes, Is a Potential Therapeutic Biomarker for Sublingual Immunotherapy: A Preliminary Report
Fujimura, T. ; Yonekura, S. ; Taniguchi, Y. ; Horiguchi, S. ; Saito, A. ; Yasueda, H. ; Nakayama, T. ; Takemori, T. ; Taniguchi, M. ; Sakaguchi, M. ; Okamoto, Y.
Int Arch Allergy Immunol 2010;153:378-387

Depigmented and Polymerised House Dust Mite Allergoid: Allergen Content, Induction of IgG4 and Clinical Response
Gallego, M.T. ; Iraola, V. ; Himly, M. ; Robinson, D.S. ; Badiola, C. ; García-Robaina, J.C. ; Briza, P. ; Carnés, J.
Int Arch Allergy Immunol 2010;153:61-69
Acceso libre